NEW YORK (GenomeWeb News) – Platypus Technologies will use a $100,000 grant from the National Institutes of Health to develop its cell motility products for use in high-throughput screening applications, the firm said on Tuesday.

The one-year Small Business Innovation Research grant will support an expansion of and modifications to the current Oris 96-well cell migration assay in order to make it compatible with automated liquid handling and high content imaging systems.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.